ACXP
Price
$4.55
Change
-$0.01 (-0.22%)
Updated
Oct 3 closing price
Capitalization
7.21M
43 days until earnings call
ATAI
Price
$5.29
Change
+$0.05 (+0.96%)
Updated
Oct 6, 11:55 AM (EDT)
Capitalization
1.22B
43 days until earnings call
Interact to see
Advertisement

ACXP vs ATAI

Header iconACXP vs ATAI Comparison
Open Charts ACXP vs ATAIBanner chart's image
Acurx Pharmaceuticals
Price$4.55
Change-$0.01 (-0.22%)
Volume$27.91K
Capitalization7.21M
ATAI Life Sciences
Price$5.29
Change+$0.05 (+0.96%)
Volume$1.38K
Capitalization1.22B
ACXP vs ATAI Comparison Chart in %
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACXP vs. ATAI commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACXP is a Hold and ATAI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ACXP: $4.55 vs. ATAI: $5.23)
Brand notoriety: ACXP and ATAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACXP: 25% vs. ATAI: 81%
Market capitalization -- ACXP: $7.21M vs. ATAI: $1.22B
ACXP [@Biotechnology] is valued at $7.21M. ATAI’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACXP’s FA Score shows that 1 FA rating(s) are green whileATAI’s FA Score has 1 green FA rating(s).

  • ACXP’s FA Score: 1 green, 4 red.
  • ATAI’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than ACXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACXP’s TA Score shows that 4 TA indicator(s) are bullish while ATAI’s TA Score has 3 bullish TA indicator(s).

  • ACXP’s TA Score: 4 bullish, 2 bearish.
  • ATAI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACXP is a better buy in the short-term than ATAI.

Price Growth

ACXP (@Biotechnology) experienced а +12.35% price change this week, while ATAI (@Biotechnology) price change was -0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.47%. For the same industry, the average monthly price growth was +12.91%, and the average quarterly price growth was +83.71%.

Reported Earning Dates

ACXP is expected to report earnings on Nov 18, 2025.

ATAI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($1.22B) has a higher market cap than ACXP($7.21M). ATAI YTD gains are higher at: 293.233 vs. ACXP (-72.052). ACXP has higher annual earnings (EBITDA): -10.05M vs. ATAI (-115.96M). ATAI has more cash in the bank: 95.9M vs. ACXP (6.06M). ACXP has less debt than ATAI: ACXP (66.5K) vs ATAI (9.22M). ATAI has higher revenues than ACXP: ATAI (2.31M) vs ACXP (0).
ACXPATAIACXP / ATAI
Capitalization7.21M1.22B1%
EBITDA-10.05M-115.96M9%
Gain YTD-72.052293.233-25%
P/E RatioN/AN/A-
Revenue02.31M-
Total Cash6.06M95.9M6%
Total Debt66.5K9.22M1%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACXPATAI
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNET2.550.28
+12.58%
ZW Data Action Technologies Inc
DUOL322.639.63
+3.08%
Duolingo
INTT7.870.10
+1.29%
inTEST Corp
BBUC34.060.33
+0.98%
Brookfield Business Corp
IDR35.030.29
+0.83%
Idaho Strategic Resources

ACXP and

Correlation & Price change

A.I.dvisor tells us that ACXP and CERO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACXP and CERO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACXP
1D Price
Change %
ACXP100%
-0.22%
CERO - ACXP
33%
Poorly correlated
-2.04%
HYPD - ACXP
31%
Poorly correlated
-6.42%
MGTX - ACXP
30%
Poorly correlated
+0.60%
OTLK - ACXP
29%
Poorly correlated
-0.93%
ATAI - ACXP
29%
Poorly correlated
+1.75%
More